Literature DB >> 19172642

A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis.

Antonia Ceccarelli1, Maria A Rocca, Paola Valsasina, Mariaemma Rodegher, Elisabetta Pagani, Andrea Falini, Giancarlo Comi, Massimo Filippi.   

Abstract

The purpose of this study is to define the topographical distribution of gray matter (GM) and white matter (WM) damage in patients with primary progressive multiple sclerosis (PPMS), using a multiparametric MR-based approach. Using a 3 Tesla scanner, dual-echo, 3D fast-field echo (FFE), and diffusion tensor (DT) MRI scans were acquired from 18 PPMS patients and 17 matched healthy volunteers. An optimized voxel-based (VB) analysis was used to investigate the patterns of regional GM density changes and to quantify GM and WM diffusivity alterations of the entire brain. In PPMS patients, GM atrophy was found in the thalami and the right insula, while mean diffusivity (MD) changes involved several cortical-subcortical structures in all cerebral lobes and the cerebellum. An overlap between decreased WM fractional anisotropy (FA) and increased WM MD was found in the corpus callosum, the cingulate gyrus, the left short temporal fibers, the right short frontal fibers, the optic radiations, and the middle cerebellar peduncles. Selective MD increase, not associated with FA decrease, was found in the internal capsules, the corticospinal tracts, the superior longitudinal fasciculi, the fronto-occipital fasciculi, and the right cerebral peduncle. A discrepancy was found between regional WM diffusivity changes and focal lesions because several areas had DT MRI abnormalities but did not harbor T2-visible lesions. Our study allowed to detect tissue damage in brain areas associated with motor and cognitive functions, which are known to be impaired in PPMS patients. Combining regional measures derived from different MR modalities may be a valuable tool to improve our understanding of PPMS pathophysiology. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19172642      PMCID: PMC6870625          DOI: 10.1002/hbm.20725

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  49 in total

1.  Normalized accurate measurement of longitudinal brain change.

Authors:  S M Smith; N De Stefano; M Jenkinson; P M Matthews
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

2.  A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  E Pagani; M Filippi; M A Rocca; M A Horsfield
Journal:  Neuroimage       Date:  2005-02-25       Impact factor: 6.556

3.  Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla.

Authors:  Antonia Ceccarelli; Maria A Rocca; Andrea Falini; Paola Tortorella; Elisabetta Pagani; Mariemma Rodegher; Giancarlo Comi; Giuseppe Scotti; Massimo Filippi
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

4.  Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.

Authors:  Federica Agosta; Marco Rovaris; Elisabetta Pagani; Maria Pia Sormani; Giancarlo Comi; Massimo Filippi
Journal:  Brain       Date:  2006-09-02       Impact factor: 13.501

5.  Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study.

Authors:  M Filippi; M Inglese; M Rovaris; M P Sormani; P Horsfield; P G Iannucci; B Colombo; G Comi
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

6.  Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T.

Authors:  Matilde Inglese; Sun-Jung Park; Glyn Johnson; James S Babb; Laura Miles; Hina Jaggi; Joseph Herbert; Robert I Grossman
Journal:  Arch Neurol       Date:  2007-02

7.  Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.

Authors:  Marco Rovaris; Elda Judica; Jaume Sastre-Garriga; Alex Rovira; Maria Pia Sormani; Beatrice Benedetti; Tijmen Korteweg; Nicola De Stefano; Zhaleh Khaleeli; Xavier Montalban; Frederik Barkhof; David H Miller; Chris Polman; Alan J Thompson; Massimo Filippi
Journal:  Mult Scler       Date:  2008-01-21       Impact factor: 6.312

8.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

Review 9.  MR spectroscopy in multiple sclerosis.

Authors:  Nicola De Stefano; Massimo Filippi
Journal:  J Neuroimaging       Date:  2007-04       Impact factor: 2.486

10.  Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.

Authors:  J J Kragt; A J Thompson; X Montalban; M Tintoré; J Río; C H Polman; B M J Uitdehaag
Journal:  Neurology       Date:  2008-01-09       Impact factor: 9.910

View more
  15 in total

Review 1.  MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.

Authors:  Massimo Filippi; M A Rocca
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-31       Impact factor: 3.825

Review 2.  The role of advanced magnetic resonance imaging techniques in primary progressive MS.

Authors:  Maria A Rocca; Martina Absinta; Massimo Filippi
Journal:  J Neurol       Date:  2011-08-04       Impact factor: 4.849

Review 3.  Magnetic Resonance Imaging in Multiple Sclerosis.

Authors:  Christopher C Hemond; Rohit Bakshi
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

4.  Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years.

Authors:  S Mesaros; M A Rocca; E Pagani; M P Sormani; M Petrolini; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-10       Impact factor: 3.825

Review 5.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

6.  Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype.

Authors:  Gianna Riccitelli; Maria A Rocca; Elisabetta Pagani; Maria E Rodegher; Paolo Rossi; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2010-08-25       Impact factor: 5.038

7.  The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.

Authors:  Rose Gelineau-Morel; Valentina Tomassini; Mark Jenkinson; Heidi Johansen-Berg; Paul M Matthews; Jacqueline Palace
Journal:  Hum Brain Mapp       Date:  2011-10-05       Impact factor: 5.038

8.  Myelin water imaging reflects clinical variability in multiple sclerosis.

Authors:  Shannon Kolind; Lucy Matthews; Heidi Johansen-Berg; M Isabel Leite; Steven C R Williams; Sean Deoni; Jackie Palace
Journal:  Neuroimage       Date:  2011-12-06       Impact factor: 6.556

Review 9.  Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.

Authors:  Yuan Cao; Wei Diao; Fangfang Tian; Feifei Zhang; Laichang He; Xipeng Long; Fuqinq Zhou; Zhiyun Jia
Journal:  Neuropsychol Rev       Date:  2021-02-13       Impact factor: 7.444

10.  DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.

Authors:  Emilia Sbardella; Francesca Tona; Nikolaos Petsas; Patrizia Pantano
Journal:  Mult Scler Int       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.